Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Serum Thymidine Kinase 1 – Potential Prostate Cancer Biomarker: A Clinical Study

JAKUB REZAC, LENKA HANOUSKOVA, STEPAN VESELY, KAREL KOTASKA, ALZBETA KANTOROVA, ANNA LINHARTOVA, VOJTECH FIALA, VIKTOR SOUKUP and OTAKAR CAPOUN
Anticancer Research April 2023, 43 (4) 1675-1680; DOI: https://doi.org/10.21873/anticanres.16319
JAKUB REZAC
1Department of Urology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LENKA HANOUSKOVA
2Department of Medical Chemistry and Clinical Biochemistry, Motol University Hospital, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STEPAN VESELY
3Department of Urology, Motol University Hospital, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAREL KOTASKA
2Department of Medical Chemistry and Clinical Biochemistry, Motol University Hospital, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ALZBETA KANTOROVA
1Department of Urology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANNA LINHARTOVA
1Department of Urology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
VOJTECH FIALA
1Department of Urology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
VIKTOR SOUKUP
1Department of Urology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
OTAKAR CAPOUN
1Department of Urology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: otakar.capoun{at}vfn.cz
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Levels of serum thymidine kinase 1 (STK1) (pmol/l) in patients with confirmed prostate cancer and healthy controls.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Correlation between Gleason score and levels of serum thymidine kinase 1 (STK1) (pmol/l).

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Correlation between number of risk factors for adjuvant radiotherapy (Gleason score 8-10, pT3, positive surgical margin) and levels of serum thymidine kinase 1 (STK1) (pmol/l).

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Correlation between number of risk factors for adjuvant radiotherapy (Gleason score 8-10, pT3, positive surgical margin) and levels of serum thymidine kinase 1 (STK1) (pmol/l).

Tables

  • Figures
  • Table I.
  • Table II.
  • Table III.
PreviousNext
Back to top

In this issue

Anticancer Research: 43 (4)
Anticancer Research
Vol. 43, Issue 4
April 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Serum Thymidine Kinase 1 – Potential Prostate Cancer Biomarker: A Clinical Study
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Serum Thymidine Kinase 1 – Potential Prostate Cancer Biomarker: A Clinical Study
JAKUB REZAC, LENKA HANOUSKOVA, STEPAN VESELY, KAREL KOTASKA, ALZBETA KANTOROVA, ANNA LINHARTOVA, VOJTECH FIALA, VIKTOR SOUKUP, OTAKAR CAPOUN
Anticancer Research Apr 2023, 43 (4) 1675-1680; DOI: 10.21873/anticanres.16319

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Serum Thymidine Kinase 1 – Potential Prostate Cancer Biomarker: A Clinical Study
JAKUB REZAC, LENKA HANOUSKOVA, STEPAN VESELY, KAREL KOTASKA, ALZBETA KANTOROVA, ANNA LINHARTOVA, VOJTECH FIALA, VIKTOR SOUKUP, OTAKAR CAPOUN
Anticancer Research Apr 2023, 43 (4) 1675-1680; DOI: 10.21873/anticanres.16319
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Real-world Delivery and Outcomes of Intravesical BCG for Non–muscle-invasive Bladder Cancer
  • Early Progressive Disease Predicts Poor Outcomes of Second-line VEGFR Tyrosine Kinase Inhibitor Therapy After First-line Nivolumab Plus Ipilimumab in Advanced Renal Cell Carcinoma
  • Evaluation of Quality Metrics for Dose Assessment in Field Overlap Regions of VMAT-Based Craniospinal Axis Irradiation
Show more Clinical Studies

Keywords

  • Prostate cancer
  • thymidine kinase 1
  • STK1
  • serum biomarker
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire